IP Library Granted Patent US 11,747,348
Granted Patent B2
US 11,747,348 · App. 18/064,233 · Granted Sep 5, 2023

Apparatus for measuring glycation of red blood cells and glycated hemoglobin level using physical and electrical characteristics of cells, and related methods

Inventors: Ung Hyeon Ko (Seoul, KR); Seung Jin Kang (Seoul, KR); Eun Young Park (Seoul, KR)
Assignee: ORANGE BIOMED LTD., CO.
G01N33/726B01L3/502715G01N33/49G01N33/723G01N33/80B01L2200/027B01L2200/10B01L2200/14B01L2300/0645B01L2300/087B01L2300/0816B01L2400/0403
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,747,348
App. No.
18/064,233
Granted
Sep 5, 2023
Kind
B2
Abstract

The present disclosure relates to systems and methods for measuring glycated A1c hemoglobin. A glycated hemoglobin level measuring system includes a sample testing apparatus having a microchannel that compresses a blood sample traveling through, a first pair of electrodes coupled to the microchannel, and a second pair of electrodes coupled to the microchannel. The glycated hemoglobin level measuring system further includes an analysis apparatus having sensors coupled to the first and second pairs of electrodes and configured to calculate a travel time taken by a red blood cell to pass through the first and second pairs of electrodes. The glycated hemoglobin level measuring system can use the travel time to measure a rigidity of the red blood cells and the corresponding glycated hemoglobin level.

Claims (11)

1. A method of operating a glycated hemoglobin level measuring system, comprising:

communicating an input signal (1) through a first pair of electrodes and across a first detection region, and in parallel (2) through a second pair of electrodes and across a second detection region;

detecting a first time based on a change in the input signal communicated across the first detection region, wherein the first time represents the moment a red blood cell reaches the first detection region;

detecting a second time based on a change in the input signal communicated across the second detection region, wherein the second time represents the moment the red blood cell reaches the second detection region;

calculating a time difference between the first and second times, wherein the time difference represents a travel period that is affected by a rigidity of the cell; and

determining a glycated hemoglobin level for the red blood cell based on the time difference, wherein the determined glycated hemoglobin level corresponds to the rigidity of the cell.

2. The method of claim 1 , further comprising correcting the determined glycated hemoglobin level based on a reference glycated hemoglobin level that represents one or more predetermined personalized physiological conditions of a patient that provided the cell.

3. The method of claim 1 , further comprising determining a physical characteristic of the cell based on a duration of change in impedance across the first detection region, the second detection region, or both.

4. The method of claim 1 , further comprising:

detecting an error condition when the time difference is greater than a maximum threshold, wherein the error condition represents two red blood cells that entered the first detection region at different times simultaneously passing the second detection region; and

omitting the first and the second times associated with the time difference.

Assignments (2)
CHANGE OF NAME Recorded Sep 13, 2024
From: ORANGE BIOMED LTD., CO.
To: ORANGE BIOMED CO., LTD.
Reel/Frame 068983/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2022
From: KO, UNG HYEON; KANG, SEUNG JIN; PARK, EUN YOUNG
To: ORANGE BIOMED LTD., CO.
Reel/Frame 062204/0153 →
Priority Claims (1)
KR 10-2021-0128520 · Sep 29, 2021 · national
Continuity (2)
Continuation In Part PCTKR2021018280 · Dec 3, 2021
Related Publication 20230108045A1 · Apr 6, 2023
Cited By (3)
US 12,399,185 US 12,517,109 US 12,560,522